FDMT vs BIIB: Which Stock is Better?
Side-by-side comparison of 4D Molecular Therapeutics Inc and Biogen Inc in 2026
FDMT
4D Molecular Therapeutics Inc
$8.46
BIIB
Biogen Inc
$184.02
Key Metrics Comparison
| Metric | FDMT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $533.07M | $27.01B | BIIB |
| P/E Ratio | N/A | 21.42 | BIIB |
| EPS (TTM) | $N/A | $8.59 | BIIB |
| Revenue Growth | 29.0% | -0.1% | FDMT |
| Gross Margin | -148295.8% | 78.9% | BIIB |
Analyze FDMT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FDMT or BIIB a better investment?
Comparing FDMT and BIIB: 4D Molecular Therapeutics Inc has a market cap of $533.07M while Biogen Inc has $27.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FDMT and BIIB?
FDMT (4D Molecular Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FDMT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: FDMT or BIIB?
FDMT has higher revenue growth at 29.0% vs -0.1% for BIIB.
Which company is more profitable: FDMT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -148295.8% for FDMT.
Which is the larger company: FDMT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.01B compared to $533.07M for FDMT.
Should I buy FDMT or BIIB in 2026?
Both FDMT and BIIB have investment merit. FDMT trades at $8.46 while BIIB trades at $184.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FDMT and BIIB stock?
Key differences: Market Cap ($533.07M vs $27.01B), P/E Ratio (N/A vs 21.4x), Revenue Growth (29.0% vs -0.1%), Gross Margin (-148295.8% vs 78.9%).